BiogenvsThermo Fisher Scientific

BIIB and TMO stock compared: price, dividend, valuation and results, from SEC filings.

BIIB

Biogen Inc.

$250.59

Value $36.8B

-0.42%
BIIB's page

TMO

Thermo Fisher Scientific Inc

$690.59

Value $257B

-0.11%
TMO's page

Biogen (BIIB) has a market value of $36.8B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, BIIB moved +49.6% and TMO +19.7%. The P/E is 105.8 for BIIB and 36.3 for TMO. Dividend yield: BIIB none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BIIB$36.8B

    TMO$257B

    TMO is 7.0 times BIIB

  • Revenue, 12 months

    BIIB$10.3B

    TMO$47.4B

    TMO is 4.6 times BIIB

  • Net income, 12 months

    BIIB$348M

    TMO$7.1B

    TMO is 20 times BIIB

  • Operating margin

    BIIB–

    TMO17.9%

  • ROIC

    BIIB1.3%

    TMO8.2%

    6.9 points apart

  • P/E

    BIIB105.8

    TMO36.3

    BIIB is 2.9 times TMO

  • Dividend yield

    BIIB0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    BIIB-4.2%

    TMO+9.2%

    13.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BIIB-4.2%

TMO+9.2%

507510012520222023202420252026
Returns by period
PeriodBIIBWith dividendsTMOWith dividends
1 year since November 14, 2025+49.6%Price +49.6%+19.7%Price +19.3%
3 years since November 17, 2023+9.9%+3.2% a yearPrice +9.9%+49.5%+14.3% a yearPrice +48.1%
5 years since November 16, 2021-4.2%-0.9% a yearPrice -4.2%+9.2%+1.8% a yearPrice +7.7%
10 years since November 17, 2016-21.5%-2.4% a yearPrice -21.5%+377.1%+16.9% a yearPrice +363.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BIIBBiogenTMOThermo Fisher Scientific

Valuation

BIIBTMO
Valuation
Price$250.59$690.59
Market value$36.8B$257B
Enterprise value (EV)$42.8B$292B
P/E105.836.3
P/E, 5-year median20.032.7
P/B1.94.7
EV/EBIT96.134.5
Free cash flow yield5.6%3.0%

Results and growth

BIIBTMO
Results and growth
Revenue, 12 months$10.3B$47.4B
Net income, 12 months$348M$7.1B
Free cash flow, 12 months$2.1B$7.6B
Earnings per share, 12 months$2.32$18.96
Revenue growth, year on year2.2%3.9%
Revenue growth a year, past-6.0%over 5 years+6.7%over 5 years
EPS growth a year, past-18.7%over 5 years+2.1%over 5 years

Margins and returns on capital

BIIBTMO
Margins and returns on capital
Gross margin74.0%–
Operating margin–17.9%
Net margin3.4%14.9%
ROIC1.3%8.2%
ROE1.9%13.4%

Balance sheet

BIIBTMO
Balance sheet
Cash$1.3B$6.1B
Total debt$7.4B$41.4B
Net debt / EBITDA4.93.7
Interest cover1.5×5.5×

Dividends and buybacks

BIIBTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BIIB or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Biogen or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 7.0 times Biogen ($36.8B), at today's prices.

How did BIIB and TMO stock do over the last 10 years?

Since November 17, 2016, BIIB's price moved -21.5% and TMO's +363.9%. With dividends: BIIB -21.5% (-2.4% a year), TMO +377.1% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, BIIB or TMO?

The dividend yield at today's price is none for Biogen and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of BIIB and TMO?

At today's price, the P/E is 105.8 for BIIB and 36.3 for TMO. The median of the last five years was 20.0 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Biogen or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 3.4% for Biogen and 14.9% for Thermo Fisher Scientific, and the operating margin – and 17.9%. Revenue was $10.3B and $47.4B.

Which is the better investment, Biogen or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.